The Hemangioma Interventional Therapy Department of Kyoto Children's Hospital mainly treats the following diseases:

1. Hemangioma category: Infantile hemangioma, strawberry hemangioma, cavernous hemangioma, mixed hemangioma, etc.

2. Vascular malformation category: Capillary malformation (such as port-wine stain), venous malformation, arteriovenous malformation, arteriovenous fistula, etc.

3. Lymphatic malformation category: Microcystic lymphatic malformation, macrocystic lymphatic malformation, lymphatic fistula, lymphedema, etc., including abdominal, retroperitoneal and mesenteric lymphangioma.

4. Other vascular-related diseases: Glomus tumor, vascular stenosis, vascular embolism, renovascular hypertension, Budd-Chiari syndrome, arteritis, etc.

5. Congenital diseases: Congenital hepatic vascular malformation, congenital pulmonary vascular malformation, congenital portosystemic shunt, etc.

6. Pediatric tumor-related: Retinoblastoma, hepatoblastoma, hepatic hemangioma, splenic hemangioma, etc.

7. Superficial masses: Epidermoid cyst, calcifying epithelioma, poroma, sebaceous cyst, lipoma, etc.

8. Pigmentary diseases: Nevus of Ota, café-au-lait spot, Mongolian spot, etc.

9. Skin scar-related: Hypertrophic scar, keloid.

10. Others: Neurofibromatosis, pyogenic granuloma, hairy nevus, etc. It also performs DSA-guided insertion/removal of children's infusion ports.

The advantages of the Interventional Hemangioma Department of Kyoto Children's Hospital are mainly reflected in its strong expert team, advanced diagnosis and treatment technologies, and high-quality hospital platform, as detailed below:

- Strong Expert Team

The department has renowned experts such as Director Shen Gang, who is the founder of China's first hemangioma and interventional vascular center. He also serves as Chairman of the Pediatric Interventional Expert Committee of the National Health Commission's Capacity Building and Continuing Education Center, and has deeply participated in compiling the *Guidelines for the Diagnosis and Treatment of Hemangiomas and Vascular Malformations by the Plastic Surgery Branch of the Chinese Medical Association (2024)*. With nearly 30 years of clinical experience, Director Shen has performed or participated in over 50,000 interventional surgeries and receives more than 6,000 outpatient visits annually. He has been awarded the "National Annual Excellent Doctor" title seven times by patients. He has extensive experience in diagnosing and treating pediatric hemangiomas, particularly excelling in minimally invasive interventional treatment for young patients.

- Advanced and Diverse Diagnostic and Treatment Technologies  

The department offers a variety of characteristic diagnostic and treatment technologies, including comprehensive treatment for infantile hemangiomas, interventional therapy for venous malformations, arteriovenous malformations/fistulas, lymphatic malformations/fistulas, and lymphedema, laser therapy for capillary malformations, and DSA-guided insertion/removal of children's infusion ports. These technologies enable personalized and precise treatment plans for different types of hemangiomas and vascular malformations.

- High-Quality Hospital Platform  

Beijing Kyoto Children's Hospital is a tertiary children's hospital in northern Beijing, accredited by JCI. It is also a designated medical institution for Beijing's medical insurance, a designated hospital for the transfer and consultation network of critically ill newborns in Beijing, and has received a credit rating of AAA and a five-star capability evaluation. The hospital has complete department settings and a central laboratory, which provides technical support and research backing for clinical departments, meeting the needs of various patients and laying a solid foundation for the development of the Interventional Hemangioma Department.

- Emphasis on Academic Exchange and Research  

The hospital attaches great importance to research investment and talent echelon building. Under the leadership of nationally renowned experts, various departments actively carry out domestic and international academic exchanges and research cooperation. Experts from the Interventional Hemangioma Department have participated in establishing China's first pediatric interventional treatment base, built a pediatric interventional training system, and host the annual China Pediatric Interventional Forum. These efforts help the department keep abreast of cutting-edge medical knowledge and technologies, continuously improving its diagnostic and treatment capabilities.

• Local puncture injection for hemangioma: This is a treatment method that directly injects drugs into the hemangioma through puncture technology to achieve therapeutic purposes.

• Image-guided sclerotherapy: Using imaging equipment (such as X-ray, ultrasound, etc.) for guidance, sclerosing agents are injected into the hemangioma to make it harden and gradually shrink.

• 595 pulsed dye laser technology: A technology that uses a laser with a specific wavelength (595nm) to treat hemangiomas. The thermal effect of the laser closes the blood vessels in the hemangioma.

• Minimally invasive interventional diagnosis and treatment technology: Diagnosing and treating hemangiomas through minimally invasive surgery to reduce surgical trauma.

• Ultra-fine puncture needle interventional guidance technique: Using ultra-fine puncture needles for interventional treatment, which allows for more precise positioning and treatment of hemangiomas.

• Local puncture injection for hemangioma (duplicate entry): Same as the second item, possibly to emphasize the importance of this technology.

• Pediatric neurointerventional technology: A neurointerventional technology specifically for children, used to treat hemangiomas related to the nervous system.

The Interventional Hemangioma Department of Kyoto Children's Hospital has achieved fruitful results in research and academic output, mainly reflected in participating in the compilation of guidelines, hosting academic forums, and writing medical works, as detailed below:

- Participation in guideline compilation: Experts from the department have deeply participated in compiling the Guidelines for the Diagnosis and Treatment of Hemangiomas and Vascular Malformations by the Plastic Surgery Branch of the Chinese Medical Association (2024), providing an important basis for standardized diagnosis and treatment in the industry.

- Hosting academic forums: The expert team has established China's first pediatric interventional treatment base and a pediatric interventional training system. They host the annual China Pediatric Interventional Forum, which promotes academic exchanges and development in the field of pediatric intervention and drives the popularization and improvement of domestic pediatric interventional technologies.

- Writing medical works: They have also participated in compiling medical works such as Pediatric Interventional Radiology, Illustrated Practical Clinical Interventional Diagnosis and Treatment, CT and MRI Interventional Radiology, and Practical Clinical Imaging Anatomy and Imaging Diagnosis, providing valuable reference materials for medical workers in related fields.

- "A facial hemangioma was found on my child shortly after birth. We went to several hospitals locally, but the treatment results were not satisfactory. Later, we heard that the Interventional Hemangioma Department of Kyoto Children's Hospital is very professional, so we took our child to see Director Shen Gang. The director was extremely patient, explained the condition and treatment plan in detail. Minimally invasive interventional therapy was used, so the child didn't need surgery. The recovery was quick, and now the hemangioma has basically subsided with no obvious traces left on the appearance. We are really grateful to them!"

- "My child has a relatively complex venous malformation. I had been worried about the risks of treatment before. When seeking treatment at Kyoto Children's Hospital, the doctor team formulated a personalized treatment plan. The whole process was very standardized, and they would communicate the child's situation with us in a timely manner. After six months of follow-up after treatment, the effect has been stable, and the child can live a normal life. The medical staff in the department are particularly patient with the child, which alleviated our anxiety as parents. The experience was very good."

- "We are patients from other cities. At first, we were not familiar with the medical procedures. Unexpectedly, the hospital has special guidance services. The child received laser treatment, each treatment session was not long, and the child cried very little. During the treatment, the doctor would adjust the plan according to the recovery situation, which was very meticulous. Now the color of the child's hemangioma has obviously lightened, and the scope has shrunk a lot. We finally don't have to worry about this anymore. Sincerely recommend it to parents with similar situations!"

- "The child's hemangioma is in a special location, close to the eye. We had been worried that the treatment would affect eyesight. Director Shen Gang's team held multiple consultations and adopted the ultra-fine puncture needle interventional guidance technique, which was highly accurate, and the treatment process went very smoothly. Postoperative re-examination showed that the hemangioma is gradually shrinking and has no impact on the eye. The technology of the department is indeed advanced, which makes us parents feel particularly at ease."